![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
JL Hylden and GL Wilcox
Mice were tested for antinociceptive activity after intrathecal injection of opioid or noradrenergic agonists by lumbar puncture. Opioid agonists with mu or delta activity and adrenergic agonists with alpha activity demonstrated dose-related, receptor-mediated analgesia in the tail-flick assay, s.c. hypertonic saline assay and the intrathecal substance P behavioral assay. Inhibition of substance P- induced biting and scratching by intrathecally administered antinociceptive agents is likely mediated by post-synaptic receptors. This action of opioids and norepinephrine was antagonized by their respective pharmacological antagonists. Subanalgesic doses of Leu- enkephalin or norepinephrine potentiated the antinociceptive activity of morphine in the substance P assay. Similarly, opioid agonists potentiated the action of norepinephrine. These results suggest that opioid and alpha adrenergic agonists act on separate receptors to produce a synergistic inhibition of the transmission of nociceptive information at the spinal level.
This article has been cited by other articles:
|
|
 |
|
  A. Dobolyi, H. Ueda, H. Uchida, M. Palkovits, and T. B. Usdin Anatomical and physiological evidence for involvement of tuberoinfundibular peptide of 39 residues in nociception PNAS, January 24, 2002; (2002) 42416199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Inoue, S. Matsunaga, M. H. Rashid, A. Yoshida, K. Mizuno, T. Sakurada, H. Takeshima, and H. Ueda Pronociceptive Effects of Nociceptin/Orphanin FQ (13-17) at Peripheral and Spinal Level in Mice J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 213 - 219. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Bohn, F. Xu, R. R. Gainetdinov, and M. G. Caron Potentiated Opioid Analgesia in Norepinephrine Transporter Knock-Out Mice J. Neurosci., December 15, 2000; 20(24): 9040 - 9045. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Inoue, I. Shimohira, A. Yoshida, A. Zimmer, H. Takeshima, T. Sakurada, and H. Ueda Dose-Related Opposite Modulation by Nociceptin/Orphanin FQ of Substance P Nociception in the Nociceptors and Spinal Cord J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 308 - 313. [Abstract] [Full Text]
|
|
|
|
|
|
C. A. Fairbanks and G. L. Wilcox Moxonidine, a Selective alpha 2-Adrenergic and Imidazoline Receptor Agonist, Produces Spinal Antinociception in Mice J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 403 - 412. [Abstract] [Full Text]
|
|
|
|
|
|
C. A. Fairbanks and G. L. Wilcox Spinal Antinociceptive Synergism between Morphine and Clonidine Persists in Mice Made Acutely or Chronically Tolerant to Morphine J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 1107 - 1116. [Abstract] [Full Text]
|
|
|
|
|
|
L. S. Stone, L. B. MacMillan, K. F. Kitto, L. E. Limbird, and G. L. Wilcox The alpha 2a Adrenergic Receptor Subtype Mediates Spinal Analgesia Evoked by alpha 2 Agonists and Is Necessary for Spinal Adrenergic-Opioid Synergy J. Neurosci., September 15, 1997; 17(18): 7157 - 7165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Dobolyi, H. Ueda, H. Uchida, M. Palkovits, and T. B. Usdin Anatomical and physiological evidence for involvement of tuberoinfundibular peptide of 39 residues in nociception PNAS, February 5, 2002; 99(3): 1651 - 1656. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
